Last reviewed · How we verify
NCT04062474
Epidural Intervention of Spinal Nerves With Tumor Necrosis Factor-Alpha Inhibitor
NA trial testing Epidural Intervention with TNF-α inhibitor in Spinal Stenosis in 90 participants. Completed in 1 May 2017.
15 December 2016
Quick facts
| Lead sponsor | Nanjing First Hospital, Nanjing Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 15 May 2016 |
| Primary completion | 15 December 2016 |
| Estimated completion | 1 May 2017 |
Drugs / interventions tested
- Epidural Intervention with TNF-α inhibitor
Conditions studied
- Spinal Stenosis — all drugs for Spinal Stenosis →
Sponsor
Nanjing First Hospital, Nanjing Medical University
Who can join
Adults 50 to 80, any sex, with Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to assess the clinical efficacy of epidural injections with Tumor Necrosis Factor-Alpha(TNF-α) Inhibitor in patients with chronic radicular pain caused by lumbar spinal stenosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Randomized trial of 3-drug combination for lumbar nerve root epidural injections with a TNF-α inhibitor in treatment of lumbar stenosis.
Wei P, Xu Y, Yao Q, Wang L. · · 2020 · cited 8× · PMID 31955619 · DOI 10.1080/02688697.2020.1713990
Verify or expand the search:
- PubMed search for NCT04062474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spinal Stenosis
Currently open trials in the same condition.
- NCT07348419 — Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery · NA · recruiting
- NCT06233617 — Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery · Phase 4 · recruiting
- NCT06950853 — ESCAPE : Evaluation of Spinal Conservation by Endoscopic Procedures to Avoid Fusion · recruiting
- NCT06120231 — Pulse-Width Modulation · NA · recruiting
- NCT06140927 — Effect of Ketamine on Intraoperative Motor Evoked Potentials · Phase 3 · recruiting
Other Nanjing First Hospital, Nanjing Medical University trials
Trials by the same sponsor.
- NCT07349979 — PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy · NA · not yet recruiting
- NCT07505056 — Jianpi Lishi Jiedu Granules for Prevention of Postoperative Recurrence in Colorectal Advanced Adenomas · Phase 3 · not yet recruiting
- NCT07397234 — Thyroid Cartilage Plane VS Superior Laryngeal Nerve Space Block in Awake Tracheal Intubation · NA · not yet recruiting
- NCT07455448 — Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study · completed
- NCT07385885 — Ultrasound-guided Non-invasive Simulation in Anesthesia Residency Training · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04062474 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanjing First Hospital, Nanjing Medical University
- Last refreshed: 20 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04062474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing